三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
N-Momentum:伊奈利珠单抗vs.安慰剂在AQP4-IgG+NMOSD患者中的疗效结果(RCP)
N-Momentum:伊奈利珠单抗vs.安慰剂在AQP4-IgG+NMOSD患者中的疗效结果(RCP)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:81KB
图片尺寸:1819*816
同报告图片
/
4
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
5qC55o2u5Zu+54mH5Lit55qE5pWw5o2u77yM5Lul5LiL5piv6KGo5qC877yaCgp8IOeWvueXheexu+WIqyAgICAgICAgICAgfCDmr5TkvosgKCUpIHwKfC0tLS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18Cnwg5YW25LuW55a+55eFICAgICAgICAgICB8IDgxICAgICAgIHwKfCDogr/nmKQgICAgICAgICAgICAgICB8IDkgICAgICAgIHwKfCDkuK3mnqLnpZ7nu4/ns7vnu5/nlr7nl4UgICB8IDEwICAgICAgIHwKCui1hOaWmeadpea6kO+8mkdCRO+8jOWNjuazsOeglOeptg==
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
所属报告:
翰森制药-港股公司研究报告-创新蕴豪情龙头迎初昕-241229(111页).pdf
打包全文图表
相关数据
First-quarter 2026 macroeconomic momentum softened from late-2025
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
收藏
行业数据
2026-07-01
原图定位
查看详情
Chart 2: Other business sentiment indicators generally continued their positive momentum since the second half of 2025
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
收藏
行业数据
2026-04-22
原图定位
查看详情
Ph3ORIGIN3研究中Atacicept及安慰剂组受试者第36周uPCR及Gd-IgA1数据
IyDmlbDmja7ooajmoLwKCnwg5pe26Ze054K577yI5ZGo77yJIHwgQXRhY2ljZXB0IHVQQ1LvvIgl77yJIHwgUGxhY2VibyB1UENS77yIJe+8iSB8IEF0YWNpY2VwdCBHZC1JZ0Ex77yIJe+8iSB8IFBsYWNlYm8gR2QtSWdBMe+8iCXvvIkgfAp8LS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAwICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICB8IDAgICAgICAgICAgICAgICAgICAgICAgfCAwICAgICAgICAgICAgICAgICAgICB8CnwgNCAgICAgICAgICAgfCAtICAgICAgICAgICAgICAgICAgIHwgLSAgICAgICAgICAgICAgICAgfCAtNDMuNSAgICAgICAgICAgICAgICAgIHwgLTAuNSAgICAgICAgICAgICAgICAgfAp8IDEyICAgICAgICAgIHwgLTMwLjUgICAgICAgICAgICAgICB8IC05LjIgICAgICAgICAgICAgIHwgLTYwLjIgICAgICAgICAgICAgICAgICB8IC0yLjEgICAgICAgICAgICAgICAgIHwKfCAyNCAgICAgICAgICB8IC00MS4yICAgICAgICAgICAgICAgfCAtMTEuMyAgICAgICAgICAgICB8IC02NC41ICAgICAgICAgICAgICAgICAgfCAtMS44ICAgICAgICAgICAgICAgICB8CnwgMzYgICAgICAgICAgfCAtNDUuNyAgICAgICAgICAgICAgIHwgLTYuOCAgICAgICAgICAgICAgfCAtNjguMyAgICAgICAgICAgICAgICAgIHwgLTIuOSAgICAgICAgICAgICAgICAgfAoKCiMg6LWE5paZ5p2l5rqQICAKTkVKTe+8jOWbveS/oeivgeWIuOe7j+a1jueglOeptuaJgOaVtOeQhg==
收藏
行业数据
2026-03-13
原图定位
查看详情
RC18针对SDESSDAI剔除安慰剂评分下降情况对比其他药物
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
收藏
行业数据
2026-03-13
原图定位
查看详情
Figure 4: Leasing Momentum of Major Growth Engines for Office Demand in 2025
收藏
行业数据
2026-02-13
原图定位
查看详情
图4.德国巴登-符腾堡州布赖斯高-黑森林东区在RCP4.5情景下(2021-2050)树种适宜性分布图(节选)
fCDmoJHnp43pgILlrpzmgKfnrYnnuqcgfCDlr7nlupTpopzoibIgfAp8LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tfAp8IOmAguWunCAgICAgICAgICAgfCDmt7Hnu7/oibIgICB8Cnwg6L6D6YCC5a6cICAgICAgICAgfCDmtYXnu7/oibIgICB8Cnwg5Y+v6IO96YCC5a6cICAgICAgIHwg6buE6ImyICAgICB8Cnwg6L6D5LiN6YCC5a6cICAgICAgIHwg5qmZ6ImyICAgICB8Cnwg5LiN6YCC5a6cICAgICAgICAgfCDnuqLoibIgICAgIHwKfCDmnoHkuI3pgILlrpwgICAgICAgfCDnsonnuqLoibIgICB8CgrotYTmlpnmnaXmupDvvJrmlLnnvJboh6rlt7TnrKblt57mnpfkuJrnoJTnqbbmiYDvvIgyMDI177yJ
收藏
行业数据
2026-02-04
原图定位
查看详情
地达西尼安全性和安慰剂相当
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
收藏
行业数据
2025-11-24
原图定位
查看详情
部分口服GLP-1类药物的减重效果对比(安慰剂矫正)
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
收藏
行业数据
2025-11-19
原图定位
查看详情
GLP-1RA±amylin类疗法减重效果对比(安慰剂矫正)
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
收藏
行业数据
2025-11-19
原图定位
查看详情
部分GIP-1/GIPR/GCGR靶点药物的减重效果对比(安慰剂矫正)
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
收藏
行业数据
2025-11-19
原图定位
查看详情
“重拾自信2.0”RCP因子10分组及多空对冲净值走势(2014/02-2025/10)
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
收藏
行业数据
2025-11-07
原图定位
查看详情
“重拾自信2.0”RCP因子(2014/02-2025/10)
fCDmjIfmoIcgICAgICAgICB8IOWFqOS9k0HogqEgICB8CnwtLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLXwKfCDlubTljJbmlLbnm4rnjocgICB8IDE3LjU1JSAgICB8Cnwg5bm05YyW5rOi5Yqo546HICAgfCA3Ljg1JSAgICAgfAp8IOS/oeaBr+avlOeOhyAgICAgfCAyLjI0ICAgICAgfAp8IOaciOW6puiDnOeOhyAgICAgfCA3Ny4zMCUgICAgfAp8IOacgOWkp+WbnuaSpOeOhyAgIHwgNy40NiUgICAgIHwKCuaVsOaNruadpea6kO+8mldpbmQg6LWE6K6v77yM5Lic5ZC06K+B5Yi456CU56m25omA
收藏
行业数据
2025-11-07
原图定位
查看详情
图表44校正安慰剂影响后载脂蛋白B变化情况
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
收藏
行业数据
2025-09-28
原图定位
查看详情
Lp(a)抑制剂的疗效:校正安慰剂效应后的Lp(a)变化百分比
fCDoja/niakgICAgICAgICAgIHwg5YmC6YeP5Y+K57uZ6I2v6aKR546HICAgICAgIHwgTHAoYSnlj5jljJbnmb7liIbmr5TvvIgl77yJIHwKfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS0tfAp8IE9scGFzaXJhbiAgICAgIHwgMjI1bWcgUTEyVyAgICAgICAgICAgfCAtMTAxICAgICAgICAgICAgICAgICB8CnwgTXV2YWxhcGxpbiAgICAgfCAyNDBtZyBRRCAgICAgICAgICAgICB8IC04NiAgICAgICAgICAgICAgICAgIHwKfCBaZXJsYXNpcmFuICAgICB8IDMwMG1nIFExNlcgICAgICAgICAgIHwgLTgzICAgICAgICAgICAgICAgICAgfAp8IFBlbGFjYXJzZW4gICAgIHwgMjBtZyBRVyAgICAgICAgICAgICAgfCAtNzQgICAgICAgICAgICAgICAgICB8CnwgT2JpY2V0cmFwaWIgICAgfCAxMG1nIFFEICAgICAgICAgICAgICB8IC01NCAgICAgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jOWQhOWFrOWPuOWFrOWRiu+8jOWNjuazsOeglOeptg==
收藏
行业数据
2025-09-28
原图定位
查看详情
图表43校正安慰剂影响后Lp(a)变化情况
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
收藏
行业数据
2025-09-28
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
II/III 期关键临床研究显示伊奈利珠单抗用于 NMOSD 治疗效果优异。N-Momentum 研究旨在对比伊奈利珠单抗与安慰剂在减少 NMOSD 复发中的疗效表现,共入组 231 名患者,其 中 213 名 为 AQP4-IgG+。在 197 天的 RCP 中:1)与 安慰剂组相比,伊奈利珠单抗组在统计学上显著延长了首次 NMOSD 发作的时间,相对风险降低了 72.8%(HR=0.272);2)伊奈利珠单抗组的 NMOSD 发病率为 11.2%,安慰剂组的 NMOSD 发病率则为 42.3%,使用伊奈利珠单抗在抗 AQP4 抗体阳性的人群中发作的相对风险降低了 77.3%(HR=0.227);3)接受伊奈利珠单抗治疗的患者较安慰剂组患者相比,显著减少了累积活动性 MRI 病灶数和 NMOSD 相关住院次数。在延伸临床中,接受伊奈利珠单抗治疗超过 4 年的患者(N=75)逾 5 年(2003 天)无复发概率仍维持在 82.7%,降低复发风险疗效可持续。
行业数据
原图定位
当前图表所属:
翰森制药-港股公司研究报告-创新蕴豪情龙头迎初昕-241229(111页).pdf
表现金流量
翰森制药:仿制药收入贡献
2021年全球疾病残疾生命年(DALYs)结构
翰森制药:中枢神经系统板块收入及同比增速
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》